Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A

Background: A more effective vaccine for tuberculosis (TB) is a global public health priority. Vaccines under development will always need evaluation in endemic settings, most of which have limited resources. Adolescents are an important target population for a new TB vaccine and for other vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Wajja, Anne, Namutebi, Milly, Apule, Barbara, Oduru, Gloria, Kiwanuka, Samuel, Akello, Mirriam, Nassanga, Beatrice, Kabagenyi, Joyce, Mpiima, Juma, Vermaak, Samantha, Lawrie, Alison, Satti, Iman, Verweij, Jaco, Cose, Stephen, Levin, Jonathan, Kaleebu, Pontiano, Tukahebwa, Edridah, McShane, Helen, Elliott, Alison M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338128/
https://www.ncbi.nlm.nih.gov/pubmed/30687792
http://dx.doi.org/10.12688/wellcomeopenres.14736.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338128/
https://www.ncbi.nlm.nih.gov/pubmed/30687792
http://dx.doi.org/10.12688/wellcomeopenres.14736.1

Ejemplares similares